Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Hepatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Novel Non-Invasive Liver Fibrosis Tests Are Effective Biopsy Alternatives
February 2026
Novel non-invasive liver disease assessments (NILDAs) are effective liver biopsy alternatives for fibrosis, a 2026 systematic review has found.
Read more
22 Jun 2021
Dynamic AFP-R and Patient Outcomes After Liver Transplant for Hepatocellular Carcinoma
Karim Halazun, Associate Professor of Surgery, Weill Cornell Medicine, New York City, New York, USA, and colleagues explored whether the dynamic α-fetoprotein response (AFP-R) could improve pre-operative prediction of patient outcomes.
22 Jun 2021
A Novel Immunotherapeutic Approach to Combat Hepatitis B
Globally, chronic hepatitis B virus (HBV) infection is associated with substantial liver-related morbidity and mortality, causing an estimated 800,000 deaths from complications such as cirrhosis and hepatocellular carcinoma. Now, a new immunotherapy strategy identified by researchers at University College London (UCL), UK, could transform the treatment landscape of HBV.
16 Jun 2021
Liver transplant patients with HBV-related hepatocellular carcinoma
Prof. Patrizia Burra (Italy) and Prof. Ramazan Idilman (Turkey) are sharing their experience with and knowledge about HBV-related liver transplant patients with hepatocellular carcinoma including epidemiology, risk factors for HBV recurrence and current therapy.
25 Mar 2021
How Much Sugar Do You Take?
DANGERS of consuming sugar have been further investigated in a new study, which indicated that a person’s metabolism may be adversely affected with even…
25 Mar 2021
Formerly Rare Gallbladder or Bile Duct Cancer on the Rise
https://codex.wordpress.org/Excerpt
7
Mins
1 Mar 2021
Gastrointestinal Manifestations and Liver Injury: Correlation with Mortality and Clinical Outcomes in Patients with COVID-19
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) arose in December 2019 in Wuhan, China, and was noted to cause a severe respiratory distress syndrome termed coronavirus disease (COVID-19)…
2 Feb 2021
Guided by the Science of TPO-RAs
In this webinar, learn about the management of severe thrombocytopenia in adult patients with chronic liver disease undergoing planned invasive procedures.
16 Dec 2020
Can Early Liver Damage Detection with a Novel Sensor Prevent Liver Failure?
FATTY liver disease is a condition experienced by one-quarter of the population in USA and, along with liver fibrosis, does not have a quick or easy…
Loading posts...
« Previous
1
…
45
46
47
48
49
…
76
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View